A Conversation With Rhythm Pharmaceuticals: Gaining a Competitive Edge With AlphaSense

Curious how your peers in biopharmaceuticals are accelerating their due diligence and competitive landscaping workflows? Listen to this insightful conversation featuring Dave Connolly, Executive Director, Investor Relations and Corporate Communications at Rhythm Pharmaceuticals, who shares real-world examples of how he has used AlphaSense over the past 5+ years to stay up-to-date on competitors, research commercial drug launches, and track investor feedback.

In this Customer Spotlight, you will:

• Learn how Rhythm is leveraging AlphaSense’s new generative AI tools to make smarter decisions in the severe obesity and hyperphagia drug market.
• Gain insights into real-life projects where AlphaSense was crucial in helping track competitor activity and making confident, action-oriented decisions

Don’t miss this chance to gain valuable perspectives from an AlphaSense power user in the biopharma industry!